Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 8/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6579989 | 0.89 | MEN1 (0.59) | HPGDSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL6579757 | 0.89 | MEN1 (0.59) | HPGDSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL6580028 | 0.88 | L3MBTL1 (0.68) | HPGDSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL6272750 | 0.86 | HPGD (0.74) | F2RHPGDSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL11221078 | 0.84 | SMN1; SMN2 (0.64) | F2RHPGDSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL15945988 | 0.84 | KDM4E (0.60) | HPGDKMT2AMEN1ALDH1A1PARP1 | |
| SCHEMBL10975643 | 0.84 | F2R (0.73) | F2RHPGDMTNR1BALDH1A1MAPT | |
| SCHEMBL11868341 | 0.83 | F2R (0.59) | F2RHPGDSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL3362788 | 0.83 | MEN1 (0.77) | F2RHPGDSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL6582663 | 0.81 | MAPT (0.73) | HPGDSMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1359889-B1 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2006-12-20 | — | — | EP | claimed |
| US-20050091762-A1 | Primary intermediate for oxidative coloration of hair | THE PROCTER & GAMBLE COMPANY | 2005-05-05 | — | — | US | claimed |
| EP-1359889-A4 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2004-12-01 | — | — | EP | claimed |
| EP-1359889-A2 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P&G-Clairol, Inc. (US) | 2003-11-12 | — | — | EP | claimed |
| US-20030056303-A1 | Primary intermediate for oxidative coloration of hair | CLAIROL INCORPORATED | 2003-03-27 | — | — | US | claimed |
| WO-2002058630-A2 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-08-01 | — | — | WO | claimed |
| CN-102241603-A | Asymmetric synthesis method of R-or S-acebutolol | CHINESE ACAD TECH INST PHYSICS | 2011-11-16 | — | — | CN | disclosed |
| EP-1359890-A4 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2009-08-12 | — | — | EP | disclosed |
| EP-1359889-B1 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2006-12-20 | — | — | EP | disclosed |
| US-20060260072-A1 | Primary intermediate for oxidative coloration of hair | THE PROCTER & GAMBLE COMPANY | 2006-11-23 | — | — | US | disclosed |
| EP-1359891-B1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2006-03-15 | — | — | EP | disclosed |
| US-20050091762-A1 | Primary intermediate for oxidative coloration of hair | THE PROCTER & GAMBLE COMPANY | 2005-05-05 | — | — | US | disclosed |
| US-6838561-B2 | Primary intermediates for oxidative coloration of hair | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-04 | — | — | US | disclosed |
| US-20030056303-A1 | Primary intermediate for oxidative coloration of hair | CLAIROL INCORPORATED | 2003-03-27 | — | — | US | disclosed |
| US-20020157192-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-31 | — | — | US | disclosed |
| US-20020144358-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-10 | — | — | US | disclosed |
| WO-2002062308-A2 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002058631-A2 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| WO-2002058630-A2 | PRIMARY INTERMEDIATE FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-4579970-A | 1-(4'-alkylamido)-2'{1[n-(alkyl)imino]-ethyl}-phenoxy-3-alkylamino-2-propanols and use thereof | OY STAR AB (FI) | 1986-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020157192-A1 | Primary intermediates for oxidative coloration of hair | AOX1, CYC1, CBR1 | F2R 3626/4885HPGD 317/4885SMN1; SMN2 4863/4885 |
| US-20030056303-A1 | Primary intermediate for oxidative coloration of hair | COXFA4L2, COX5A, COX5B | F2R 4231/4885HPGD 159/4885SMN1; SMN2 4829/4885 |
| US-20060260072-A1 | Primary intermediate for oxidative coloration of hair | COXFA4L2, COX5A, COX5B | F2R 4189/4885HPGD 170/4885SMN1; SMN2 4844/4885 |
| US-20020144358-A1 | Primary intermediates for oxidative coloration of hair | COX5A, CYC1, MT-CO1 | F2R 4164/4885HPGD 290/4885SMN1; SMN2 4826/4885 |
| US-20050091762-A1 | Primary intermediate for oxidative coloration of hair | COXFA4L2, COX5A, COX5B | F2R 4231/4885HPGD 159/4885SMN1; SMN2 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.